If you've lost count of how many distributors Alkaline Water Company Inc. (OTCBB:WTER) has working for it now, you're not alone. Ditto for the number of grocers that are offering its flagship produce... one-gallon bottles of Alkaline84 water (some of the best-tasting and healthiest spring water you could ever drink). So many distributors and grocery store chains have just started carrying Alkaline84 within the past two months that it's been nearly impossible to keep up with how quickly WTER has gotten its ball rolling. There is one thing that's clear though - Alkaline Water Company has a LOT of momentum right now, up from none at the beginning of July. Take a look at all the doors the company has opened since it actually began marketing its bottled water:
�
July 23rd: Alkaline84's marketing launch kicks off with at least 119 locales carrying it July 25th: Southern California specialty food brokers Perimeter Sales and Merchandising and SAVI Sales and Marketing begin marketing the product July 30th: The Las Vegas Beer and Beverage Company starts promoting Alkaline 84 in Las Vegas August 1st: Arizona-based specialty food broker Cashman-Edwards begins marketing Alkaline Water Company's bottled water August 8th: Three southern California grocers put Alkaline84 on their shelves... Superior Grocers (40 locations), Vallarta Supermarkets (41 locations), and Northgate Gonzalez Markets (36 locations) August 16th: Arizona's 130-store-chain Basha's supermarkets begin offering Alkaline84 in some of its locations August 26th: United Natural Foods (UNFI) adds the WTER bottled water product to its national distribution network [UNFI is the key supplier to Wholefoods and Wild Oats] September 3rd: KeHE Distributors take on Alkaline84; KeHE serves more than 33,000 retail locations across North America September 5th: 48 of Bashas' Supermarkets stores (the Food City stores) put Alkaline84 on its shelvesThat's massive growth in a short period of time. Indeed, the most underappreciated aspect of this growth story is the sheer speed of the spread of its footprint.
Best Oil Companies To Invest In 2015: Powershares Dynamic Retail Portfolio (PMR)
PowerShares Dynamic Retail Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of an equity index called the Dynamic Retail Intellidex Index (the Retail Intellidex). The Retail Intellidex consists of stocks of 30 United States retailers. These are companies that are principally engaged in operating general merchandise stores, such as department stores, discount stores, warehouse clubs and superstores; specialty stores, including apparel, electronics, accessories and footwear stores;, and home improvement and home furnishings stores. Dealers of motor vehicles and parts, auction houses or rental companies may also be included. Stocks are selected principally on the basis of their capital appreciation potential as identified by the AMEX (the Intellidex Provider) pursuant to its Intellidex methodology. The Fund�� investment advisor is PowerShares Capital Management LLC.
The Fund will normally invest at least 80% of its total assets in common stocks of retail companies. It will normally invest at least 90% of its total assets in common stocks that comprise the Retail
Intellidex. The Fund, using an indexing investment approach, attempts to replicate the performance of the Retail Intellidex. The Fund generally will invest in all of the stocks comprising the Retail Intellidex in proportion to their weightings in the Retail Intellidex.
Advisors' Opinion:- [By Ron Rowland]
The five funds consist of three ETFs and two traditional mutual funds. The names and gains of the three ETFs were PowerShares Dynamic Retailing ETF (PMR) 0.6%, Market Vectors Retail ETF (RTH) 0.7%, and SPDR S&P Retail ETF (XRT) 1.1%.
- [By John Udovich]
Small cap Checkpoint Systems, Inc (NYSE: CKP) fights shoplifting or retail theft and other forms of�"shrink��that costs retailers over $112 billion worldwide last year (according to a study funded by the company), meaning it might be an interesting stock to take a closer look at and to compare its performance with that of SPDR S&P Retail ETF (NYSEARCA: XRT) and PowerShares Dynamic Retail ETF (NYSEARCA: PMR). Just how bad can shoplifting or shrink be for a retailer? Troubled retailer J.C. Penney Company, Inc (NYSE: JCP) has just reported that shoplifting took a full percentage point off the department store chain's profit margins during the quarter. Moreover and given that tens of millions of Americans are now facing higher health insurance costs thanks to Obamacare (which will likely impact consumer discretionary spending),�retailers�will need to find ways to shore up their margins and bottom lines by preventing�retail theft with solutions from company�� like Checkpoint Systems.
Top Supermarket Stocks To Watch Right Now: Rossi Residencial SA (RSID3)
Rossi Residencial SA is a Brazil-based company involved in the real estate sector. The Company is principally engaged in the development, construction and sale of residential and commercial real estate properties. In addition, it is involved in the subdivision of land and provision of civil engineering services. As of December 31, 2011, the Company had four subsidiaries, including Astir Assessoria Tecnica Imobiliaria e Participacoes Ltda, RCI Consultoria de Imoveis Ltda, Rossi Consultoria de Imoveis Ltda and Rossi Industria de Artefatos de Concreto Ltda, as well as a number of joint ventures, such as Argentea Empreendimentos SA, Damacena Empreendimentos SA, Minulo Empreendimentos SA and Nicandra Empreendimentos SA, among others. Advisors' Opinion:- [By Ney Hayashi]
Rossi Residencial SA (RSID3) climbed 2.1 percent today to 2.98 reais, leading homebuilders higher, as traders pared bets for higher borrowing costs in Brazil following the inflation report. The BM&FBovespa Real Estate Index added 0.5 percent.
Top Supermarket Stocks To Watch Right Now: Deluxe Corporation (DLX)
Deluxe Corporation, together with its subsidiaries, provides personalized printed products, promotional products, and merchandising materials in the United States, Canada, and Europe. Its Small Business Services segment offers printed products, including business checks, promotional products, marketing materials, and related services, as well as retail packaging supplies and a suite of business services comprising Web design and hosting, fraud protection, payroll, logo design, search engine marketing, business networking, and other Web-based services to small businesses. This segment also offers printed forms, such as billing forms, work orders, job proposals, purchase orders, invoices, and personnel forms; computer forms; and stationery, letterhead, envelopes, greeting cards and labels, and business cards in various formats and ink colors. It sells its products through mail and the Internet, referrals from financial institutions and telecommunications clients, independent distributors and dealers, and sales representatives. The company?s Financial Services segment provides check programs for personal and business checks, fraud prevention and monitoring services, customer acquisition campaigns, marketing communications, regulatory program services, and customer loyalty programs to banks, credit unions, and financial services companies primarily through direct sales force. Its Direct Checks segment sells personal and business checks, and related products and services directly to consumers through direct response marketing and the Internet. Deluxe also offers online financial management tools that provide banks with daily access to their financial position and general ledger information. The company was formerly known as Deluxe Check Printers, Incorporated and changed its name to Deluxe Corporation in 1988. Deluxe Corporation was founded in 1915 and is headquartered in Shoreview, Minnesota.
Advisors' Opinion:- [By Eric Volkman]
Deluxe (NYSE: DLX ) is opening its checkbook for a fresh round of shareholder payouts. The company has declared its latest quarterly dividend, which is to be $0.25 per share, paid on September 3 to shareholders of record as of August 19.�This is in line with the firm's long-standing distribution policy; it has handed out that amount in every quarter stretching back to July 2006.
Top Supermarket Stocks To Watch Right Now: ATA Inc.(ATAI)
ATA Inc., through its subsidiaries, provides computer-based testing services in the People?s Republic of China. It offers services for the creation and delivery of computer-based tests utilizing its test delivery platform, proprietary testing technologies, and testing services; and provides logistical support services relating to test administration. The company?s computer-based testing services are used for professional licensure and certification tests in various industries, including information technology (IT) services, banking, securities, teaching, and insurance. Its e-testing platform integrates various aspects of the test delivery process for computer-based tests ranging from test form compilation to test scoring, and results analysis. ATA also provides career-oriented educational services, such as single course programs, degree major course programs, and pre-occupational training programs focusing on preparing students to pass IT and other vocational certification tests; test preparation and training programs and services to test candidates preparing to take professional certification tests in securities, futures, banking, insurance and teaching industries; online test preparation and training platform for the securities and banking industries; and test preparation software for the teaching industry. In addition, the company offers HR select employee assessment solution, an online system that utilizes its proprietary software and an inventory of test titles to help employers improve the efficiency and accuracy of their employee recruitment process. As of March 31, 2010, it had contractual relationships with 1,988 ATA authorized test centers. The company serves Chinese governmental agencies, professional associations, IT vendors, and Chinese educational institutions, as well as individual test preparation services. ATA Inc. was founded in 1999 and is based in Beijing, the People?s Republic of China.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Industrials stocks gained Friday, with ATA (NASDAQ: ATAI) leading advancers. Meanwhile, gainers in the sector included Plug Power (NASDAQ: PLUG), with shares up 22 percent, and Korn/Ferry International (KFY), with shares up 12 percent. In trading on Friday, basic materials shares were relative laggards, down on the day by about 1.36 percent. - [By Jake L'Ecuyer]
Leading and Lagging Sectors
Industrials stocks gained Friday, with ATA (NASDAQ: ATAI) leading advancers. Meanwhile, gainers in the sector included Plug Power (NASDAQ: PLUG), with shares up 22 percent, and Korn/Ferry International (KFY), with shares up 12 percent. In trading on Friday, basic materials shares were relative laggards, down on the day by about 1.36 percent.
Top Supermarket Stocks To Watch Right Now: Cell Therapeutics Inc (CTIC)
Cell Therapeutics, Inc. (CTI), incorporated in 1991, develops, acquires and commercializes treatments for cancer. The Company�� research, development, acquisition and in-licensing activities concentrate on identifying and developing new ways to treat cancer. As of December 31, 2011, CTI focused its efforts on Pixuvri (pixantrone dimaleate) (Pixuvri), OPAXIO (paclitaxel poliglumex) (OPAXIO), tosedostat, brostallicin and bisplatinates. As of December 31, 2011, it developed Pixuvri, an anthracycline derivative for the treatment of hematologic malignancies and solid tumors. Another late-stage drug candidate of the Company, OPAXIO, is being studied as a potential maintenance therapy for women with advanced stage ovarian cancer, who achieve a complete remission following first-line therapy with paclitaxel and carboplatin. As of December 31, 2011, it also developed tosedostat in collaboration with Chroma Therapeutics, Ltd. (Chroma). On May 31, 2012, CTI completed its acquisition gaining worldwide rights to S*BIO Pte Ltd.'s (S*BIO) pacritinib.
Pixuvri
As of December 31, 2011, the Company developed Pixuvri, an aza-anthracenedione derivative, for the treatment of non-Hodgkin�� lymphoma (NHL), and various other hematologic malignancies, and solid tumors. Pixuvri was studied in the Company�� EXTEND, or PIX301, clinical trial, which was a phase III single-agent trial of Pixuvri for patients with relapsed, refractory aggressive NHL who received two or more prior therapies and who were sensitive to treatment with anthracyclines. On September 28, 2011, CTI announced that a second independent radiology assessment of response and progression endpoint data from its PIX301 clinical trial of Pixuvri was achieved with statistical significance. The results of the EXTEND trial met its primary endpoint and showed that patients randomized to treatment with Pixuvri achieved a significantly higher rate of confirmed and unconfirmed complete response compared to patients treated with standard chem! otherapy had a significantly increased overall response rate and experienced a statistically significant improvement in median progression free survival. Pixuvri had predictable and manageable toxicities when administered at the proposed dose and schedule in the EXTEND clinical trial in heavily pre-treated patients. In March 2011, the Company initiated the PIX-R trial to study Pixuvri in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Pixuvri has also been studied in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens. In the second quarter of 2010, the NCCTG opened this phase II study for enrollment. The study is closed to accrual and results are expected to be reported by the NCCTG later in 2012.
OPAXIO
OPAXIO is the Company�� biologically-enhanced chemotherapeutic agent that links paclitaxel to a biodegradable polyglutamate polymer, resulting in a new chemical entity. As of December 31, 2011, the Company focused its development of OPAXIO on ovarian, brain, esophageal, head and neck cancer. OPAXIO was designed to improve the delivery of paclitaxel to tumor tissue while protecting normal tissue from toxic side effects. In November 2010, results were presented by the Brown University Oncology Group from a phase II trial of OPAXIO combined with temozolomide (TMZ), and radiotherapy in patients with newly-diagnosed, high-grade gliomas, a type of brain cancer. The trial demonstrated a high rate of complete and partial responses and a high rate of six month progression free survival (PFS). Based on these results, the Brown University Oncology Group has initiated a randomized, multicenter, phase II study of OPAXIO and standard radiotherapy versus TMZ and radiotherapy for newly diagnosed patients with glioblastoma with an active gene termed MGMT that reduces responsiveness to TMZ. A phase I/II study of OPAXIO combined with radi! otherapy ! and cisplatin was initiated by SUNY Upstate Medical University, in patients with locally advanced head and neck cancer.
Tosedostat
In March 2011, the Company entered into a co-development and license agreement with Chroma Therapeutics, Ltd. (Chroma), providing the Company with marketing and co-development rights to Chroma�� drug candidate, tosedostat, in North, Central and South America. Tosedostat is an oral, aminopeptidase inhibitor that has demonstrated anti-tumor responses in blood related cancers and solid tumors in phase I-II clinical trials. Interim results from the phase II OPAL study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML) showed that once-daily, oral doses of tosedostat had predictable and manageable toxicities and results demonstrated response rates, including a high-response rate among patients who received prior hypomethylating agents, which are used to treat myelodysplastic syndrome (MDS), a precursor of AML.
Brostallicin
As of December 31, 2011, the Company developed brostallicin through its wholly owned subsidiary, Systems Medicine LLC, which holds rights to use, develop, import and export brostallicin. Brostallicin is a synthetic deoxyribonucleic acid (DNA) minor groove binding agent that has demonstrated anti-tumor activity and a favorable safety profile in clinical trials, in which more than 230 patients have been treated as of December 31, 2011. The Company uses a genomic-based platform to guide the development of brostallicin. A phase II study of brostallicin in relapsed, refractory soft tissue sarcoma met its predefined activity and safety hurdles and resulted in a first-line phase II clinical trial study that was conducted by the European Organization for Research and Treatment of Cancer (EORTC).
The Company competes with Bristol-Myers Squibb Company, Sanofi-Aventis, Pfizer, Roche Group, Genentech, Inc., Astellas Pharma, Eli Lilly and Company, Celgene, Telik, I! nc., TEVA! Pharmaceuticals Industries Ltd. and PharmaMar.
Advisors' Opinion:- [By Bryan Murphy]
Like it or not, all good things must come to an end.... even for a red hot stock like Cell Therapeutics Inc. (NASDAQ:CTIC). Yes, CTIC is up 111% since the end of 2013, up 14% today alone, and it doesn't look like the bulls have any reason to slow down now. That's exactly why now's the time for current shareholders to be afraid, however - expect it when you least expect it.
Top Supermarket Stocks To Watch Right Now: Books-A-Million Inc.(BAMM)
Books-A-Million, Inc. operates as a book retailer in the southeastern United States. The company operates superstores and traditional bookstores that offer a selection of hardcover and paperback books, magazines, and newspapers. It also offers other merchandise, including gifts, cards, collectibles, magazines, music, DVDs, and electronic accessories, as well as coffee, tea, and other edible products. The company markets its products under the trademarks of Books-A-Million, BAM! Books-A-Million, Bookland, Books & Co., Millionaire?s Club, Sweet Water Press, Thanks-A-Million, Big Fat Coloring Book, Up All Night Reader, Read & Save Rebate, Readables Accessories for Readers, Kids-A-Million, Teachers First, The Write-Price, Bambeanos, Hold That Thought, Book$mart, BAMM, BAMM.com, BOOKSAMILLION.com, Chillatte, Joe Muggs Newsstand, Page Pets, JOEMUGGS.com, FAITHPOINT.com, Faithmark, Joe Muggs, Anderson?s Bookland, Snow Joe, Summer Says, On the John University, OTJU, American Whole sale Book Company, AWBC, and NetCentral. It also offers its products over the Internet at Booksamillion.com. As of August 11, 2011, the company operated 231 stores in 23 states and the District of Columbia. Books-A-Million, Inc. was founded in 1917 and is based in Birmingham, Alabama.
Advisors' Opinion:- [By John Udovich]
Vitamin Shoppe Inc (NYSE: VSI), Books-A-Million, Inc (NASDAQ: BAMM) and Perfumania Holdings, Inc (NASDAQ: PERF) have the dubious distinction of being�the worst performing small cap�specialty retail stocks for this year (according to Finviz.com) with losses of 4.85% and�3% and a gain of 0.61%, respectively, since the start of the year (See my previous article: This Year�� Best Performing Small Cap Specialty Retail Stocks? UNTD, TA & HZO). I should mention that the definition of specialty retail stocks might vary from one stock screener to another, but what�� clear is that these three small cap retail stocks have been heading in the wrong direction for investors for much of this year. �With that in mind, what sort of performance should investors expect from these small cap specialty retail stocks on Black Friday and for the all important holiday season? Here is what you need to be aware of:
No comments:
Post a Comment